Articles By Topic:

Alzheimer’s Disease

Delirium Among Hospitalized AD Patients: The Long-Term Impact

Little attention has been paid to the consequences of delirium on cognitive deterioration among patients with Alzheimer’s disease

Managing Delirium Among Elderly Patients in the ED

Studies suggest that emergency physicians are often challenged by identifying and diagnosing delirium in older patients. Gaining a better understanding of delirium may help emergency physicians improve the management of these elderly patients.

Assessing Medical Decision-Making Capacity

New research shows that incapacity to make medical decisions appears to be common and is often not recognized by physicians. Several instruments are available to assist physicians in assessing medical decision-making capacity.


An Innovative Model for Dementia Care

A new collaborative model of care uses standard protocols to initiate treatment and identify, monitor, and treat behavioral and psychological symptoms of dementia, stressing non-pharmacological management.


Linking Vitamin D to Dementia

Adults who were moderately deficient or severely deficient in vitamin D had a 53% and 125% increased risk of developing dementia, respectively, in the largest study examining the link between low vitamin D levels and dementia published this month in Neurology.…

Actor Seth Rogen’s Senate Hearing on Alzheimer’s Research

Actor/Director Seth Rogen appeared on Capitol Hill recently to speak before the Senate Committee on Appropriations about the rising costs of Alzheimer’s disease on Americans, and to address the lack of funding for adequate treatment or a cure. Rogen has been married to screenwriter-actress Lauren Miller since 2011.…

Will a Drink a Day Keep Dementia Away?

Light to moderate drinking—be it of beer, wine, or spirits—seems to reduce the risk for dementia and cognitive decline, according to a study recently released in Neuropsychiatric Disease and Treatment.…


A New Alzheimer Disease Biomarker?

Visinin-like protein-1 (VILIP-1) and VILIP-1/ Aβ42—potential cerebrospinal fluid (CSF) markers of neuronal injury—appear to predict the rate of global cognitive decline similarly to tau and tau/Aβ42, markers long known to be involved in Alzheimer’s disease, according to findings from a small study.…

Call to Action Encourages Screenings for Abuse & Violence

The American Academy of Neurology has issued a position statement calling for clinicians to screen patients for abusive or violent treatment by family members, caregivers, and/or others. Available for free at, the statement notes that patients with neurologic disorders—especially Parkinson’s, Alzheimer’s, or stroke—might be at higher risk for abuse and neglect than others.…

eMedia - Alzheimer’s Disease




Physician's Weekly for Current Medical News, Events & Issues